Bicycle Therapeutics (BCYC) Payables: 2018-2025
Historic Payables for Bicycle Therapeutics (BCYC) over the last 7 years, with Sep 2025 value amounting to $12.7 million.
- Bicycle Therapeutics' Payables rose 121.44% to $12.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.8 million, marking a year-over-year increase of 73.74%. This contributed to the annual value of $15.8 million for FY2024, which is 21.02% up from last year.
- Latest data reveals that Bicycle Therapeutics reported Payables of $12.7 million as of Q3 2025, which was down 30.72% from $18.3 million recorded in Q2 2025.
- Bicycle Therapeutics' 5-year Payables high stood at $18.3 million for Q2 2025, and its period low was $996,000 during Q1 2021.
- Over the past 3 years, Bicycle Therapeutics' median Payables value was $8.5 million (recorded in 2023), while the average stood at $9.8 million.
- Per our database at Business Quant, Bicycle Therapeutics' Payables crashed by 77.54% in 2021 and then soared by 301.51% in 2022.
- Bicycle Therapeutics' Payables (Quarterly) stood at $2.7 million in 2021, then surged by 137.85% to $6.5 million in 2022, then skyrocketed by 101.64% to $13.1 million in 2023, then increased by 21.02% to $15.8 million in 2024, then surged by 121.44% to $12.7 million in 2025.
- Its Payables stands at $12.7 million for Q3 2025, versus $18.3 million for Q2 2025 and $11.1 million for Q1 2025.